Cleared Traditional

K222803 - Oncospace

K222803 is an FDA 510(k) clearance for Oncospace, manufactured by Oncospace, Inc.. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K222803 · Oncospace, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
139d
Days
Class 2
Risk

K222803 is an FDA 510(k) clearance for the Oncospace. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Oncospace, Inc. (Baltimore, US). The FDA issued a Cleared decision on February 2, 2023 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oncospace, Inc. devices

FDA 510(k) Submission Details - K222803

510(k) Number K222803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2022
Decision Date February 02, 2023
Days to Decision 139 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 107d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 147
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K222803.
RayStation 12A
K222312 · RaySearch Laboratories AB (PUBL) · Mar 2023
RT Elements (4.0)
K223279 · Brainlab AG · Mar 2023
Monaco RTP System
K223233 · Elekta Solutions AB · Feb 2023
syngo.via RT Image Suite
K220783 · Siemens Medical Solutions USA, Inc. · Sep 2022
MRI Planner
K211841 · Spectronic Medical AB · Aug 2022
ClearCalc Model RADCA V2
K220582 · Radformation, Inc. · Aug 2022